Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients

Gallium-68 DOTATATE provides physiologic imaging and assists in disease localization for somatostatin receptor (SSTR) positive neuroendocrine tumor (NET) patients. However, questions regarding usefulness of gallium- 68 DOTATATE imaging in identifying the primary site in neuroendocrine tumors (NETS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Aman, El-Khouli, Riham, Waits, Timothy, Agrawal, Rohitashva, Siddiqui, Fariha, Tarter, Zachary, Horn, Millicent, Weiss, Heidi, Oates, Elizabeth, Evers, B. Mark, Anthony, Lowell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429177/
https://www.ncbi.nlm.nih.gov/pubmed/32850010
http://dx.doi.org/10.18632/oncotarget.27695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429177/
https://www.ncbi.nlm.nih.gov/pubmed/32850010
http://dx.doi.org/10.18632/oncotarget.27695

Ejemplares similares